Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00423800
Status:
TERMINATED
Last Update Posted:
2017-04-07
First Post:
2007-01-17
Brief Title:
Efficacy and Safety of 24 vs 48 Weeks of Pegetron Peginterferon Alfa-2b Ribavirin in Naïve Genotype 1 Hepatitis C Study P05016TERMINATED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hepatitis C Chronic |
Keywords: